Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Operating activities
Net loss	$ (13,154,671)	$ (7,125,655)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	1,628,558	1,373,958
Change in operating assets and liabilities:
Prepaid expenses and other assets	(396,834)	(116,676)
Inventory	(236,480)
Accounts payable and accrued liabilities	416,426	106,280
Accrued interest expense	112,994
Milestone payable	5,000,000
Net cash used in operating activities	(6,630,007)	(5,762,093)
Financing activities
Proceeds from issuance of common stock from ATM, net	3,595,713	6,106,922
Proceeds from issuance of common stock from employee stock purchase plan	119,416
Proceeds from issuance of common stock from stock options exercises	215,816
Proceeds from paycheck protection program	104,168
Proceeds from Eversana line of credit	5,000,000
Net cash provided by financing activities	9,035,113	6,106,922
Net increase in cash and cash equivalents	2,405,106	344,829
Cash and cash equivalents at beginning of period	5,663,833	5,319,004
Cash and cash equivalents at end of period	$ 8,068,939	$ 5,663,833